Uzbekistan Cough Syrup
-
{
- All
- News
-
Indian Among 21 Sentenced In Uzbekistan Over Cough Syrup Deaths
Uzbekistan on Monday handed out sentences to 21 people linked to the deaths of 68 children who consumed a contaminated cough syrup produced in India.
-
Uzbekistan Syrup Deaths: Noida Firm's Licence Cancelled By Uttar Pradesh
The manufacturing licence of Noida-based pharmaceutical firm Marion Biotech was cancelled on Wednesday by Uttar Pradesh authorities, according to officials.
-
After Uzbekistan Syrup Deaths, Regulator's Big Move Against Delhi Firm
India's drug regulator directed drug manufacturers not to use propylene glycol supplied by a Delhi-based company which provided the ingredient to Marion Biotech, whose cough syrups were alleged to have led to the deaths of children in Uzbekistan.
-
Uzbekistan Syrup Deaths: Process Initiated To Cancel Noida Firm's Licence
The process has been initiated for cancellation of the drug licence of pharmaceutical firm Marion Biotech, which is allegedly linked with the death of 18 children in Uzbekistan who consumed their cough syrup in December 2022, officials in Noida said.
-
WHO May Issue Advisory Against Cough Syrups For Children: Report
Citing "unacceptable levels" of toxins in the products, the WHO is seeking information about the raw materials used by six manufacturers in India and Indonesia
-
Noida Firm Behind Syrup Linked To 18 Uzbekistan Deaths To Halt All Production
A deviation from schedule M of Good Manufacturing Practice (GMP), a system for ensuring that products are consistently produced and controlled according to quality standards, was observed at Marion's plant.
-
Indian Among 21 Sentenced In Uzbekistan Over Cough Syrup Deaths
Uzbekistan on Monday handed out sentences to 21 people linked to the deaths of 68 children who consumed a contaminated cough syrup produced in India.
-
Uzbekistan Syrup Deaths: Noida Firm's Licence Cancelled By Uttar Pradesh
The manufacturing licence of Noida-based pharmaceutical firm Marion Biotech was cancelled on Wednesday by Uttar Pradesh authorities, according to officials.
-
After Uzbekistan Syrup Deaths, Regulator's Big Move Against Delhi Firm
India's drug regulator directed drug manufacturers not to use propylene glycol supplied by a Delhi-based company which provided the ingredient to Marion Biotech, whose cough syrups were alleged to have led to the deaths of children in Uzbekistan.
-
Uzbekistan Syrup Deaths: Process Initiated To Cancel Noida Firm's Licence
The process has been initiated for cancellation of the drug licence of pharmaceutical firm Marion Biotech, which is allegedly linked with the death of 18 children in Uzbekistan who consumed their cough syrup in December 2022, officials in Noida said.
-
WHO May Issue Advisory Against Cough Syrups For Children: Report
Citing "unacceptable levels" of toxins in the products, the WHO is seeking information about the raw materials used by six manufacturers in India and Indonesia
-
Noida Firm Behind Syrup Linked To 18 Uzbekistan Deaths To Halt All Production
A deviation from schedule M of Good Manufacturing Practice (GMP), a system for ensuring that products are consistently produced and controlled according to quality standards, was observed at Marion's plant.
